Rilexia Tablets 250 mg (Chlorphenesin Carbamate)

Adult dose

Adults: Administer 250㎎ of chlorphenesin carbamate orally three times daily. Adjust the dose as appropriate according to age and symptoms.

This medication should not be used by individuals who have had allergic reactions to this medication or similar medications in the past. It is also advisable to avoid administering this medication to patients with liver function impairment. Patients with a history of liver dysfunction or kidney dysfunction should use this medication cautiously. During the use of this medication, allergic symptoms such as skin rash or swelling may occur, so it should be discontinued immediately if these symptoms appear. Occasionally, neurological symptoms such as drowsiness, dizziness, headache, or lethargy may occur, and if these symptoms arise, measures such as reducing the dosage or discontinuing the medication should be taken. Gastrointestinal symptoms such as indigestion, nausea, abdominal pain, and loss of appetite may also occur. Rarely, side effects resulting in a decrease in blood cell count may occur, so caution is needed. Severe skin conditions such as toxic epidermal necrolysis may arise, so skin conditions should be closely monitored, and use should be discontinued if abnormalities occur. This medication can cause drowsiness and decreased concentration, so it is advisable to avoid driving or operating hazardous machinery while taking it. The safety of long-term use has not been fully established, so regular blood tests and liver function tests are recommended. Caution is advised if taken with other central nervous system depressants or certain psychiatric medications, as well as with alcohol, as this may enhance the effect, and in unavoidable cases, the dosage should be reduced. Pregnant women or women who may become pregnant should consult a doctor before taking this medication, and it is advisable for breastfeeding women not to take this medication. The safety of this medication has not been fully established in children or adolescents, so it is preferable not to use it in these populations. Elderly patients may have decreased physical function, so caution should be exercised and the dosage reduced when using this medication.

Rash, swelling, drowsiness, dizziness, headache, heaviness, weakness, fatigue, nausea, vomiting, abdominal pain, abdominal discomfort, feeling of fullness in the stomach, loss of appetite, dry mouth, leukopenia, thrombocytopenia, toxic epidermal necrolysis (Stevens-Johnson syndrome)

This medication should be stored in a sealed container to prevent air or moisture from entering, and it is advisable to keep it at a temperature between 1°C and 30°C at room temperature. Storing it this way can help maintain the medication's effectiveness and prevent degradation.

Appearance

It is a white circular tablet.

Package unit

30 tablets/bottle, 500 tablets/bottle